Main Article Content
tuberculosis exposed, latent tuberculosis infection, active tuberculosis infection, multi-drug resistant tuberculosis
Background and Objectives: Migration flux is an increasing phenomenon in Italy, and it raises several public health issues and concerns in pediatric infectious diseases. This study investigated the clinical characteristics and outcomes of a pediatric population at high-risk for tuberculosis (TB) and the potential role of immigration as a risk factor.
Design: We performed an observational retrospective study of children referred to the only Pediatric Infectious Diseases Unit for Northern Sardinia over a 6-year-period (2009-2014). Main variables assessed included TB skin test (TST), confirmed by quantiFERON Gold in Tube test, thorax X-ray (TX), microbiological culture, direct microscopy for acid-fast bacilli and molecular assays.
Results: Of the 246 children (mean age = 5.8 ± 3.9 years) identified, 222 (90.2%) were native to Sardinia and 24 (9.8%) were immigrants. The majority of children (n=205; 83%) were TB-exposed but not infected based on a negative TST and TX. Among the TST positive group (n= 39; 16%), 19 (49%) had latent TB (TX negative), while 20 (51%) had active TB (TX positive). The percent of TST positive children was significantly higher in the immigrant than the native group (42.5% versus 14%, p<0.001). Clinical presentations included pulmonary involvement with hilar lymphadenopathy (72%), pleurisy (13,5%), lateral-cervical lymphadenopathy (9%), pneumonia with calcifications (4.5%) and disseminated TB (4.5%). One child had multidrug-resistant tuberculosis.
Conclusions: Pediatric TB represents a relevant and potentially worsening public health problem in Northern Sardinia. A strict surveillance system and appropriate treatment can prevent the most severe forms and reduce TB transmission.
2. Abubakar I, Griffiths C, Ormerod P. Diagnosis of active and latent tuberculosis: summary of NICE guidance. BMJ 2012; 345: e6828.
3. WHO. Global tuberculosis report 2014. World Health Organization, Geneva; 2014 http://www.who.int/tb/publications/global_report/en/. (accessed Nov 12, 2014)
4. Tebruegge M, Salo E, Ritz N, Kampmann B. On Behalf Of The Paediatric Tuberculosis Network European Trialsgroup Ptbnet (2013) Inclusion of latent tuberculosis infection as a separate entity into the international classification of diseases. Thorax 68: 588. thoraxjnl-2012-202824.
5. Buonsenso D, Sali M, Focarelli B, Onesimo R, Palucci I, Delogu G, et al. The tuberculosis spectrum: Translating basic research into pediatric clinical practice. Med Hypotheses. 2015 Oct 28. pii: S0306-9877(15)00410-7.
6. Sali M, Buonsenso D, Goletti D, D'Alfonso P, Zumbo A, Fadda G, et al. Accuracy of QuantiFERON-TB Gold Test for Tuberculosis Diagnosis in Children. PLoS One. 2015 Oct 6;10(10):e0138952. doi: 10.1371/journal.pone.0138952.
7. Eurosurveillance Editorial Team. ECDC and WHO/Europe joint report on tuberculosis surveillance and monitoring in Europe. Euro Surveill. 20140;19(11). pii: 20741.
8. Durando P, Alicino C, Orsi A, Barberis I, Paganino C, Dini G, et al. Latent tuberculosis infection among a large cohort of medical students at a teaching hospital in Italy. Biomed Res Int. 2015;2015:746895.
9. Chiappini E, Bonsignori F, Orlandini E, Sollai S, Venturini E, Galli L, de Martino M. Increasing incidence of tuberculosis in Tuscan youth, 1997 to 2011. Pediatr Infect Dis J. 2013; 32(11):1289-91
10. Bua A, Molicotti P, Cannas S, Ruggeri M, Olmeo P, Zanetti S. Tuberculin skin test and QuantiFERON in children. New Microbiol. 2013;36 (2):153-6.
11. Molicotti P., Bua A., Mela G., Olmeo P., Ortu S., Sechi L.A., et al. Performance of Quantiferon TB testing in a outbrak at a primary school J. Pediatr. 2008; 152 (4): 585-86
12. Graham SM. Treatment of paediatric TB: revised WHO guidelines. Paediatr Respir Rev. 2011;12 (1):22-6.
13. Santiago B, Baquero-Artigao F, Mejías A, Blázquez D, Jiménez MS, Mellado-Peña MJ; EREMITA Study Group. Pediatric drug-resistant tuberculosis in Madrid: family matters. Pediatr Infect Dis J. 2014;33 (4):345-50.
14. Pang J, Teeter LD, Katz DJ, Davidow AL, Miranda W, Wall K, et al. Tuberculosis Epidemiologic Studies Consortium. Epidemiology of tuberculosis in young children in the United States. Pediatrics. 2014;133(3):e494-504.
15. Durando P, Sotgiu G, Spigno F, Piccinini M, Mazzarello G, Viscoli C, et al. Latent tuberculosis infection and associated risk factors among undergraduate healthcare students in Italy: a cross-sectional study. BMC Infect Dis. 2013;13:443
16. Galli L, Lancella L, Tersigni C, Venturini E, Chiappini E, Bergamini BM, et al. Pediatric Tuberculosis in Italian Children: Epidemiological and Clinical Data from the Italian Register of Pediatric Tuberculosis. Int J Mol Sci. 2016 Jun 17;17(6). pii: E960. doi: 10.3390/ijms17060960.
17. Garazzino S, Galli L, Chiappini E, Pinon M, Bergamini BM, Cazzato S, et al.; SITIP IGRA Study Group. Performance of interferon-? release assay for the diagnosis of active or latent tuberculosis in children in the first 2 years of age: a multicenter study of the Italian Society of Pediatric Infectious Diseases. Pediatr Infect Dis J. 2014 Sep;33(9):e226-31.